Gelteq Ltd
NASDAQ:GELS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Wastbygg Gruppen AB (publ)
STO:WBGR B
|
SE |
Gelteq Ltd
Long-Term Debt
Gelteq Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gelteq Ltd
NASDAQ:GELS
|
Long-Term Debt
AU$13.6k
|
CAGR 3-Years
-79%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Long-Term Debt
AU$8.7m
|
CAGR 3-Years
402%
|
CAGR 5-Years
190%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Long-Term Debt
AU$2.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Long-Term Debt
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Long-Term Debt
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
Long-Term Debt
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gelteq Ltd
Glance View
Gelteq Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2024-10-29. Gelteq Limited is an Australia-based clinical and science-based company. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
See Also
What is Gelteq Ltd's Long-Term Debt?
Long-Term Debt
13.6k
AUD
Based on the financial report for Jun 30, 2025, Gelteq Ltd's Long-Term Debt amounts to 13.6k AUD.
What is Gelteq Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
-79%
Over the last year, the Long-Term Debt growth was -99%. The average annual Long-Term Debt growth rates for Gelteq Ltd have been -79% over the past three years .
